Health CanadaType I
APO-AMITRIPTYLINE Tablets: NNORT impurity
Published: August 14, 2023Recall ID: 74114Category: generalCountry: Canada
Reason for Recall / Hazard
Contamination
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
APO-AMITRIPTYLINE Tablets
Additional Source Details
| Field | Value |
|---|---|
| N I D | 74114 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/apo-amitriptyline-tablets-nnort-impurity |
| Issue | Contamination |
| Title | APO-AMITRIPTYLINE Tablets: NNORT impurity |
| Product | APO-AMITRIPTYLINE Tablets |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2023-08-14 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |